Sigma Healthcare Limited
SIG
Classifica tra le azioni
#1048
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Prezzo delle azioni
$1.95
Capitalizzazione di mercato
$22.39B
Variazione (1 giorno)
-0.18%
Variazione (1 anno)
-1.35%
Paese
AU
Scambia Sigma Healthcare Limited (SIG)
Categoria
Healthcare
Ricavi di Sigma Healthcare Limited (SIG)
Ricavi nel Jun 2026 TTM: $7.64B
Secondo gli ultimi rapporti finanziari di Sigma Healthcare Limited, i ricavi attuali dell'azienda (TTM) sono pari a $7.64B. Nel 2024, l'azienda ha registrato ricavi di $2.18B una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $2.58B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Sigma Healthcare Limited da 2001 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $7.64B | 150.36% |
| 2025 | $3.05B | 39.95% |
| 2024 | $2.18B | -15.49% |
| 2023 | $2.58B | 5.96% |
| 2022 | $2.44B | -5.99% |
| 2021 | $2.59B | 19.30% |
| 2020 | $2.17B | -24.90% |
| 2019 | $2.89B | -12.38% |
| 2018 | $3.30B | -0.28% |
| 2017 | $3.31B | 35.12% |
| 2016 | $2.45B | 0.35% |
| 2015 | $2.44B | -6.25% |
| 2014 | $2.60B | -15.90% |
| 2013 | $3.10B | 1.20% |
| 2012 | $3.06B | 4.45% |
| 2011 | $2.93B | 27.32% |
| 2010 | $2.30B | 4.91% |
| 2009 | $2.19B | -18.21% |
| 2008 | $2.68B | 26.67% |
| 2007 | $2.12B | 27.55% |
| 2006 | $1.66B | 531.67% |
| 2004 | $262.65M | 32.71% |
| 2003 | $197.92M | 42.01% |
| 2002 | $139.37M | 98.14% |
| 2001 | $70.34M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $410.98B | 5,278.14% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,227.10% |
US
|
|
| - | - |
US
|
|
| $13.60B | 78.00% |
US
|
